BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38233558)

  • 1. Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study.
    Bagheri A; Moradi S; Iraji A; Mahdavi M
    Sci Rep; 2024 Jan; 14(1):1540. PubMed ID: 38233558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties.
    Noori M; Sabourian R; Tasharoie A; Safavi M; Iraji A; Khalili Ghomi M; Dastyafteh N; Irajie C; Zarenezhad E; Mostafavi Pour SM; Rasekh F; Larijani B; Amini M; Hajimahmoodi M; Mahdavi M
    Sci Rep; 2023 Feb; 13(1):2578. PubMed ID: 36782003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors.
    Alizadeh N; Hossein Sayahi M; Iraji A; Yazzaf R; Moazzam A; Mobaraki K; Adib M; Attarroshan M; Larijani B; Rastegar H; Khoshneviszadeh M; Mahdavi M
    Bioorg Chem; 2022 Sep; 126():105876. PubMed ID: 35623142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors.
    Mahdavi M; Ashtari A; Khoshneviszadeh M; Ranjbar S; Dehghani A; Akbarzadeh T; Larijani B; Khoshneviszadeh M; Saeedi M
    Chem Biodivers; 2018 Jul; 15(7):e1800120. PubMed ID: 29766648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies.
    Ashraf J; Mughal EU; Sadiq A; Bibi M; Naeem N; Ali A; Massadaq A; Fatima N; Javid A; Zafar MN; Khan BA; Nazar MF; Mumtaz A; Tahir MN; Mirzaei M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7107-7122. PubMed ID: 32799758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ugi Bis-Amide Derivatives as Tyrosinase Inhibitor; Synthesis, Biology Assessment, and in Silico Analysis.
    Yousefnejad F; Iraji A; Sabourian R; Moazzam A; Tasharoie S; Sara Mirfazli S; Zomorodian K; Alireza Akhlagh S; Hosseini S; Larijani B; Tehrani MB; Hajimahmoodi M; Mahdavi M
    Chem Biodivers; 2023 Jan; 20(1):e202200607. PubMed ID: 36538729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
    Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
    Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
    Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, in Vitro, and in Silico Evaluation of N-Phenylacetamide-Oxindole-Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors.
    Yari Boroujeni S; Haghighijoo Z; Mohammadi-Khanaposhtani M; Mosadeghkhah A; Moazzam A; Yavari A; Hajimahmoodi M; Sabourian R; Hosseini S; Larijani B; Hamedifar H; Ansari S; Mahdavi M
    Chem Biodivers; 2022 Apr; 19(4):e202100666. PubMed ID: 35156774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the tyrosinase inhibitory potential of phenolics from Centaurium spicatum: Bridging in silico and in vitro perspectives.
    Alruhaimi RS; Mahmoud AM; Elbagory I; Ahmeda AF; El-Bassuony AA; Lamsabhi AM; Kamel EM
    Bioorg Chem; 2024 Jun; 147():107397. PubMed ID: 38691905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors.
    Hajimiri M; Khosravikia M; Khoshneviszadeh M; Pedrood K; Hosseini SZ; Asgari MS; Pirhadi S; Attarroshan M; Mobaraki K; Hosseini S; Behnammanesh H; Biglar M; Karimian S; Rastegar H; Hamedifar H; Larijani B; Mahdavi M; Iraji A
    Chem Biodivers; 2022 Jul; 19(7):e202100964. PubMed ID: 35675562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold.
    Kim SJ; Yang J; Lee S; Park C; Kang D; Akter J; Ullah S; Kim YJ; Chun P; Moon HR
    Bioorg Med Chem; 2018 Aug; 26(14):3882-3889. PubMed ID: 29907470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
    Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Kinetics and Computational Explorations of 4-Phenylpiperazine Bearing N-(Aryl)-3-substituted-benzamides as Auspicious Tyrosinase Inhibitors.
    Zeb A; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Hassan M; Javed Q; Rafiq M; Ali A; Shah SAA; Kloczkowski A
    Chem Biodivers; 2024 Apr; 21(4):e202400133. PubMed ID: 38363553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of novel pyrimidine derivatives as a new class of mushroom tyrosinase inhibitor.
    Mirmortazavi SS; Farvandi M; Ghafouri H; Mohammadi A; Shourian M
    Drug Des Devel Ther; 2019; 13():2169-2178. PubMed ID: 31371919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazol-4(5H)-one analogs as potent tyrosinase inhibitors: Synthesis, tyrosinase inhibition, antimelanogenic effect, antioxidant activity, and in silico docking simulation.
    Jung Park Y; Jin Jung H; Jin Kim H; Soo Park H; Lee J; Yoon D; Kyung Kang M; Young Kim G; Ullah S; Kang D; Park Y; Chun P; Young Chung H; Ryong Moon H
    Bioorg Med Chem; 2024 Jan; 98():117578. PubMed ID: 38154348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies.
    Ashraf J; Mughal EU; Alsantali RI; Obaid RJ; Sadiq A; Naeem N; Ali A; Massadaq A; Javed Q; Javid A; Sumrra SH; Zafar MN; Ahmed SA
    Bioorg Med Chem; 2021 Apr; 35():116057. PubMed ID: 33610011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase and α-glucosidase inhibitory potential of compounds isolated from Quercus coccifera bark: In vitro and in silico perspectives.
    Sari S; Barut B; Özel A; Kuruüzüm-Uz A; Şöhretoğlu D
    Bioorg Chem; 2019 May; 86():296-304. PubMed ID: 30738329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.